141 related articles for article (PubMed ID: 29212235)
1.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Oncotarget; 2017 Nov; 8(55):94382-94392. PubMed ID: 29212235
[TBL] [Abstract][Full Text] [Related]
2. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
[TBL] [Abstract][Full Text] [Related]
3. Pathological Implications of Receptor for Advanced Glycation End-Product (
Serveaux-Dancer M; Jabaudon M; Creveaux I; Belville C; Blondonnet R; Gross C; Constantin JM; Blanchon L; Sapin V
Dis Markers; 2019; 2019():2067353. PubMed ID: 30863465
[TBL] [Abstract][Full Text] [Related]
4. AGER genetic polymorphisms increase risks of breast and lung cancers.
Yin NC; Lang XP; Wang XD; Liu W
Genet Mol Res; 2015 Dec; 14(4):17776-87. PubMed ID: 26782423
[TBL] [Abstract][Full Text] [Related]
5. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.
Kinjo T; Kitaguchi Y; Droma Y; Yasuo M; Wada Y; Ueno F; Ota M; Hanaoka M
Sci Rep; 2020 Jul; 10(1):12811. PubMed ID: 32732977
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of six polymorphisms in the receptor for advanced glycation end products to type 2 diabetes: a systematic review and meta-analysis.
Cheng H; Zhu W; Zhu M; Sun Y; Sun X; Jia D; Yang C; Yu H; Zhang C
Endocr J; 2021 Aug; 68(8):993-1010. PubMed ID: 33840670
[TBL] [Abstract][Full Text] [Related]
7. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.
Shao Y; Shao X; He J; Cai Y; Zhao J; Chen F; Tao H; Yin Z; Tan X; He Y; Lin Y; Li K; Cui L
Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264
[TBL] [Abstract][Full Text] [Related]
8. Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese.
Pan H; Niu W; He L; Wang B; Cao J; Zhao F; Liu Y; Li S; Wu H
PLoS One; 2013; 8(7):e69018. PubMed ID: 23874853
[TBL] [Abstract][Full Text] [Related]
9. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
[TBL] [Abstract][Full Text] [Related]
10. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics.
Chou YE; Hsieh MJ; Wang SS; Lin CY; Chen YY; Ho YC; Yang SF
J Cell Mol Med; 2021 Nov; 25(22):10761-10769. PubMed ID: 34708514
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel advanced glycation end products receptor gene variants associated with colorectal cancer in Tunisians: A case-control study.
Bedoui SA; Barbirou M; Stayoussef M; Dallel M; Mokrani A; Makni L; Mezlini A; Bouhaouala-Zahar B; Yacoubi-Loueslati B; Almawi WY
Gene; 2020 Sep; 754():144893. PubMed ID: 32544495
[TBL] [Abstract][Full Text] [Related]
12. Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.
Zhao DC; Lu HW; Huang ZH
J BUON; 2015; 20(2):614-24. PubMed ID: 26011358
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Li T; Qin W; Liu Y; Li S; Qin X; Liu Z
Cancer Cell Int; 2017; 17():19. PubMed ID: 28184178
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus.
Goulart AC; Germer S; Rexrode KM; Martin M; Zee RY
Clin Chim Acta; 2008 Dec; 398(1-2):95-8. PubMed ID: 18796298
[TBL] [Abstract][Full Text] [Related]
16. A multicenter matched case-control analysis on seven polymorphisms from HMGB1 and RAGE genes in predicting hepatocellular carcinoma risk.
Wang D; Qi X; Liu F; Yang C; Jiang W; Wei X; Li X; Mi J; Tian G
Oncotarget; 2017 Jul; 8(30):50109-50116. PubMed ID: 28187002
[TBL] [Abstract][Full Text] [Related]
17. Association of
Hu D; Liu Q; Lin X; Zhang H; Lin J; Zheng X; Peng F
J Cancer; 2019; 10(2):504-509. PubMed ID: 30719146
[No Abstract] [Full Text] [Related]
18. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration.
Banevicius M; Vilkeviciute A; Kriauciuniene L; Liutkeviciene R; Deltuva VP
Med Sci Monit; 2018 Jan; 24():190-199. PubMed ID: 29317590
[TBL] [Abstract][Full Text] [Related]
20. Association of
Kolonaite G; Vilkeviciute A; Kriauciuniene L; Gedvilaite G; Liutkeviciene R
Ophthalmic Genet; 2021 Dec; 42(6):685-690. PubMed ID: 34338585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
